最も実用的!最速!最安値!
ペプチド形状(7~12残基長)の次世代抗体!
Next generation antibodies in the form of peptides (7~12 residues long)!
↓↓↓↓↓↓↓↓↓↓↓↓↓↓↓↓
↓↓↓↓↓
1)新型コロナウイルス等病原微生物
→診断薬、(中和活性を有する)治療薬
2)各種がん抗原
→ペプチド薬物複合体 Peptide-Drug Conjugate
3)GPCR
→GPCR作動薬
Our company, GeneTry,Inc. has developed an extremely versatile technology to replace antibody drugs, named Antibody-Like-Peptide Aptamer (ALPA); a screening system for Medium molecular drugs.
By utilizing the Display method, screening of APA clones against any antigen target can be completed within 6 days.
APA is a peptide drug of 15 amino acids or less in length and, unlike antibodies, has a much smaller molecular weight. The molecular weight is much smaller than that of antibodies (typically 1/100 of the molecular weight of antibodies).
↓↓↓↓↓
Features and advantages;
1)Excellent tissue penetration rate.
2)Easy to construct multiple specificity.
3)Easy to recombination with other functional molecules.
4)Peptides can be chemically synthesized because they are less than 15 amino acids long.
5)Peptide aptamer sequences can serve as basic data for AI drug discovery.
Application areas;
1) New coronaviruses
→Diagnostic agent, therapeutic agent (with neutralizing activity)
2) Various cancer antigens
→Peptide-Drug Conjugate
3) GPCRs
→GPCR agonist